ProCE Banner Activity

Optimal Selection of Therapy for Treatment-Naive Chronic Lymphocytic Leukemia

Slideset Download
Download this slideset from a live symposium at ASH 2021 for expert perspectives on best practices in treating patients with newly diagnosed CLL.

Released: December 09, 2021

Expiration: December 08, 2022

No longer available for credit.

Share

Faculty

Asher Chanan-Khan

Asher Chanan-Khan, MD

Associate Professor of Oncology
Attending Physician
, Department of Medicine
Member, Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, New York

Provided by

Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Genentech, a member of the Roche Group

Janssen Biotech Pharmacyclics Abbvie

Faculty Disclosure

Primary Author

Asher Chanan-Khan, MD

Associate Professor of Oncology
Attending Physician
, Department of Medicine
Member, Department of Pharmacology and Therapeutics
Roswell Park Cancer Institute
Buffalo, New York